The 2017 clinical practice guidelines from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) recommend using the following sex-specific cutoff values for screening metabolic-associated fatty liver disease: ALT ≥ 2 times the upper limit of normal, defined as >52 IU/L for males and >44 IU/L for females [1]. Here, GPT is linked to fatty liver disease.